Shares of Sernova Corp. (TSE:SVA – Get Free Report) reached a new 52-week low during trading on Wednesday . The stock traded as low as C$0.28 and last traded at C$0.29, with a volume of 31575 shares trading hands. The stock had previously closed at C$0.28.
Analyst Upgrades and Downgrades
Separately, Raymond James set a C$1.50 price target on shares of Sernova and gave the company a “market perform” rating in a research note on Thursday, April 4th.
View Our Latest Analysis on Sernova
Sernova Price Performance
Sernova (TSE:SVA – Get Free Report) last posted its quarterly earnings results on Friday, June 14th. The company reported C($0.03) earnings per share for the quarter, meeting analysts’ consensus estimates of C($0.03). On average, research analysts forecast that Sernova Corp. will post -0.08 earnings per share for the current year.
Sernova Company Profile
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Recommended Stories
- Five stocks we like better than Sernova
- How to Choose Top Rated Stocks
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- Compound Interest and Why It Matters When Investing
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.